Eventide Healthcare & Life Sciences Fund CLASS I SHARES (ETIHX)

Fund Assets	1.13B
Expense Ratio	1.32%
Min. Investment	$100,000
Turnover	n/a
Dividend (ttm)	n/a
Dividend Yield	n/a
Dividend Growth	n/a
Payout Frequency	n/a
Ex-Dividend Date	n/a

Previous Close	30.94
YTD Return	-6.92%
1-Year Return	-9.10%
5-Year Return	-5.23%
52-Week Low	26.90
52-Week High	38.04
Beta (5Y)	0.77
Holdings	86
Inception Date	Dec 27, 2012

About ETIHX

The investment seeks to provide long-term capital appreciation. Under normal market conditions, the fund invests at least 80% of its net assets (plus borrowings for investment purposes) in equity and equity-related securities of companies in the healthcare and life sciences sectors, including common stock, options, preferred stock and convertible debt. It may invest without limitation in securities of companies domiciled outside the United States either directly or through American Depositary Receipts ("ADRs"). The fund may invest in securities of companies of any market capitalization.

• Category: Health
• Performance Rating: Below Average
• Risk Rating: High
• Stock Exchange: NASDAQ
• Ticker Symbol: ETIHX
• Share Class: Class I Shares
• Index: S&P Biotechnology Select Industry TR

Performance

ETIHX had a total return of -9.10% in the past year, including dividends. Since the fund's inception, the average annual return has been 11.66%.

Other Share Classes

These are alternative share classes of the same fund, from the same provider.

Symbol	Share Class	Expense Ratio
ETNHX	Class N Shares	1.52%
ETAHX	Class A Shares	1.57%
ETCHX	Class C Shares	2.32%

Top 10 Holdings

33.84% of assets

Name	Symbol	Weight
Verona Pharma plc	VRNA	4.41%
Scholar Rock Holding Corporation	SRRK	3.97%
Mirum Pharmaceuticals, Inc.	MIRM	3.73%
US BANK MMDA - USBGFS 9	n/a	3.68%
Insmed Incorporated	INSM	3.60%
Guardant Health, Inc.	GH	3.43%
Blueprint Medicines Corporation	BPMC	2.93%
Collegium Pharmaceutical, Inc.	COLL	2.85%
Celldex Therapeutics, Inc.	CLDX	2.65%
Aura Biosciences, Inc.	AURA	2.59%